Specifically, variant c.521T > C within SLCO1B1 was found to have a significantly increased risk of hyperbilirubinemia (OR = 2.544, 95% CI: 1.267–5.11, P = 0.009). This evidence concerns the gene SLCO1B1 and Hyperbilirubinemia.